Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Recently developed genomics-based tools are allowing repositioning of Food and Drug Administration (FDA)-approved drugs as cancer treatments, which were employed to identify drugs that target cancer stem cells (CSCs) of breast cancer. Gene expression datasets of CSCs from six studies were subjected...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bhat-Nakshatri, Poornima, Goswami, Chirayu P., Badve, Sunil, Sledge, George W., Nakshatri, Harikrishna
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3965360/
https://ncbi.nlm.nih.gov/pubmed/23982413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep02530
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky